Corbus Pharmaceuticals Holdings, Inc.
(NASDAQ : CRBP)

... ...
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.10%125.140.0%$2517.24m
BNGOBioNano Genomics, Inc. -11.93%8.050.0%$1626.30m
GILDGilead Sciences, Inc. 1.37%67.991.0%$696.88m
AMGNAmgen, Inc. 1.65%252.361.3%$574.64m
CRSPCRISPR Therapeutics AG -4.30%189.770.6%$516.52m
REGNRegeneron Pharmaceuticals, Inc. 1.57%542.272.7%$477.27m
ALXNAlexion Pharmaceuticals, Inc. -0.61%157.742.0%$471.04m
NVAXNovavax, Inc. -2.31%125.0592.9%$463.88m
ILMNIllumina, Inc. 3.42%403.543.5%$395.72m
SRPTSarepta Therapeutics, Inc. -0.04%96.7613.8%$351.95m
VRTXVertex Pharmaceuticals, Inc. 2.07%236.701.9%$351.25m
BIIBBiogen, Inc. -1.30%270.281.7%$328.68m
BNTXBioNTech SE -1.40%103.230.0%$308.28m
OCGNOcugen, Inc. -4.70%2.230.0%$294.71m
PACBPacific Biosciences of California, Inc. -4.02%38.597.4%$258.16m

Company Profile

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.